Generic and innovative drugs market in Poland 2012

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Generic and innovative drugs market in Poland 2012
Published on May 2012

Report Summary

Generic and innovative drugs market in Poland 2012- Development forecasts for 2012-2014

Generic and innovative drugs market in Poland 2012, Development forecasts for 2012-2014 is a comprehensive source of data and
analysis focused on recent and impending changes in the market resulting from the January 2012 reimbursement act. This legislation
has the power to change the framework of the Polish pharmaceutical sector, particularly the generic and innovative drug segments,
and the report guides readers to a thorough understanding of the act's provisions and offers ways for companies to adapt to the new
rules and preserve their profits.

In addition to providing complete forecasts for these two segments, as well as for the overall pharmaceutical industry in Poland to
2014, this document supplies data on the market share occupied by these two drug categories in terms of value and volume, and
prices of innovative drugs and generics in Poland and as compared to other markets. It simplifies complex issues such as the Polish
reimbursement process, upcoming changes to reimbursement and the lists of reimbursed and non-reimbursed drugs, fixed outlays of
the National Health fund, payment structures and operations of therapies vs. medications.

Topics essential to manufacturers and producers of generic and innovative drugs include: evaluation of the effects of the new act on
major market players, suggested methods of limiting potentially harmful effects to businesses, changes in prices of top products in
these categories, changes to reimbursements and refund status, role of the AOTM and other agencies in the reimbursement decision
process, recent price negotiations with government agencies, funding limits and fixed prices and margins.

Generic and innovative drugs market in Poland 2012, Development forecasts for 2012-2014 contains vital data on the current market,
explanation of all changes due to new regulation and projects for the future of this important part of the pharmaceutical industry.

Table of Content

Development forecasts for 2012-2014

1. Report methodology 7
2. Executive summary 11
3. Overview of the generic and innovative drugs market in Poland 15
4. Main trends and events 15
5. Main past trends and events 15
6. Main anticipated trends and events 25
7. Share of pharmaceutical market 29
8. Overall market 29
9. Rx pharmacy market 30
10. Market size and forecasts for 2012-2014 31

Generic and innovative drugs market in Poland 2012 (From Slideshare) Page 1/5


11. Overall market 31
13. Counterfeit products 34
14. Drug reimbursement in Poland 37
15. Pricing policies 37
16. VAT rate 37
17. Non-reimbursed drugs on the pharmacy market 38
18. Reimbursed drugs on the pharmacy market 38
19. Pricing policies 38
20. Prices compared to other countries 40
21. Patient co-payment 41
22. The value of sales of reimbursed drugs 42
23. Margins 43
24. Drugs on the hospital market 44
25. Generic substitution 44
26. Reimbursement policies 46
27. Reimbursement system 46
28. Open (pharmacy) reimbursement 46
29. Therapeutic/drug programmes 47
30. Chemotherapy 50
31. Reimbursement process 50
32. Reimbursement application 52
33. The Economic Committee 52
34. The AOTM 53
35. Risk-sharing tools 54
36. Market structure 54
37. Regular prescriptions and prescriptions for drugs for chronic diseases 54
38. Reimbursement spending from the state's and the patient's perspective 55
39. Type of payment 56
40. ATC categories 57
41. Reimbursement spending 58
42. Open reimbursement 58
43. Therapeutic programmes 61
44. Chemotherapy 61
45. Hospital segment 63
46. Funding 63
47. Drug selection 63
48. Drug procurement 63
49. Distribution 64
50. Off-label use 64
51. Latest changes to reimbursement lists 65
52. Inclusion of new drugs in reimbursement lists 65
53. Latest changes to reimbursement lists 67
54. Controversies 70
55. Expected changes to reimbursement lists 72
56. Reimbursement reform ' Reimbursement Act 73
57. Major changes 73
58. Fixed spending on reimbursement and the pay-back mechanism 74



59. Joint-limit groups 75
60. Assessment of the Reimbursement Act's effect on market players 76
61. Reducing the negative impact of the Reimbursement Act 78
62. Key market players 81
63. Market share 81
64. Whole market 81
66. Hospital market 84
67. Innovation ranking 85
68. Innovation projects ' Innovative Economy Operational Programme 86
69. Profiles of selected key market players 87
70. Innovative companies 87
71. Generic companies 105
72. List of graphs 123
73. List of tables 127
74. About PMR 129
75. Contact PMR 130


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 660.00 Quantity: _____

1-5 User License--USD 3 990.00 Quantity: _____

Corporate License--USD 5 320.00 Quantity: _____

Global Site--USD 6 650.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Generic and innovative drugs market in Poland 2012

Recomendados

Recomendados

Mais conteúdo relacionado

Mais de ReportLinker.com

Mais de ReportLinker.com (20)

Generic and innovative drugs market in Poland 2012